Cannabis Law Report

JUNE 16, 2021

If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain. Hemp-derived Delta-8 THC is having a big moment in 2021 in terms of popularity and, most recently, in terms of concerns over legality, safety, and accuracy.

THC 90

THC Hemp Media Data 90

Cannabis Law Report

MARCH 7, 2020

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71

Hemp CBD Research and Development Safety 71

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 49

Safety Food CBD Oil 49

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 30, 2021

I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. With new census data, control of Congress on a knife-edge and redistricting just ahead, there couldn’t be a better time to dive into the numbers.”. Media: Sperry Mylott, 860.277.5075. 22 – “High Risk? smylott@travelers.com.

Programs 81

Programs Data Policy Topical 81

Cannabis Law Report

SEPTEMBER 15, 2021

The FDA is aware of media reports of delta-8 THC products getting consumers “high.” Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. exposures to any substance(s).

THC 105

THC Pets Events Hemp 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 8, 2021

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. and are difficult to predict. cbdMD, Inc. John Weston. Director of Investor Relations.

Research and Development 85

Research and Development Pets Cannabinoids Clinical Trials 85

The Blunt Truth

AUGUST 13, 2019

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The FDA is collecting data to fill these gaps. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

SpeedWeed

JULY 25, 2021

Here are the applicants and their scores with notable MSO losses in red text: Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media.

Media 52

Media Data Dispensary Access 52

SpeedWeed

JULY 7, 2021

Here’s how the 282 acres stacked up by license type: Figuring out cultivation size nationally is probably more art than science given the data gaps that exist. Currently, Oklahoma has 7,754 licenses according to the Cannabiz Media License Database – but there is no limit to how much cannabis an Oklahoma cultivator can grow.

Cultivation 52

Cultivation Media Data Compliance 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

SpeedWeed

JULY 8, 2021

Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Ed has managed product, marketing, and sales while overseeing complex multijurisdictional product lines in the securities, corporate, UCC, safety, environmental, and human resource markets. .

Media 52

Media Data Retail Concentrates 52

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . triggering new innovations and improved data quality through better user experiences.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

The Blunt Truth

MAY 26, 2020

In his statement, Commissioner Hahn noted that the FDA was working on: 1) continuing to educate the public on the risks of CBD; 2) seeking reliable data on the safety and benefits of CBD, including opening the public docket on the matter; and 3) monitoring the marketplace for the sale and marketing of unapproved drugs.

CBD 103

CBD Hemp Programs Food 103

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

SpeedWeed

JULY 6, 2021

Safety data is limited, and testing for CRC contamination is missing—even in legalization states. Many legal and illicit hashmakers now use a ‘color remediation column’—often a steel cylinder (column) packed with a filtration media like sand—during extraction to filter impurities. What is CRC tech? How safe is CRC hash?

Hash 52

Hash Media Extraction Oil 52

Medicinal Genomics

SEPTEMBER 27, 2018

Within this blog post, we have identified the statements included in the Analytical Cannabis article that Medicinal Genomics knows to be false, those that are true, as well as supplemental data on our position on each specific issue. This is an assumption that works well in short-form media but fails under any prolonged scientific scrutiny.

Food 69

Food Data Safety Patients 69

WeedAdvisor

JULY 21, 2019

The Financial Times explains: “The excitement over cannabis in Colombia has reached fever pitch with some local media reports suggesting the country could supply two-fifths of the world’s marijuana and earn more from it than it does from coal or cut flowers. The checklist is endless, but every box needs to be marked.

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

Veriheal

AUGUST 12, 2021

The authors added that in spite of the growing availability and diversity of alternative cannabinoid products like artisanal CBD—as opposed to pharmaceutical CBD—existing studies assessing their efficacy and/or safety are extremely rare. The majority of patients (74%) were Caucasian and more than half (55%) identified as female.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Miss Marijuana

JUNE 30, 2019

I mean duh, with social media, bosses that don’t understand you have a life and the new Bob Dylan documentary on Netflix – how can anyone doze off and dream anymore? And who doesn’t feel that dark cloud of stress, anxiety and drag get bigger when they’re tossing and turning all night? So what’s next?

Sleep 72

Sleep CBD Clinical Trials Oil 72

Puff Puff Post

FEBRUARY 24, 2020

These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.

CBD 52

CBD Safety Pharmaceutical Media 52

Greenspoon Marder Cannabis Law Group Blog

OCTOBER 8, 2019

The Center for Disease Control (CDC), the federal agency that is on the front lines for any threat to public health, works closely with FDA and state health departments to gather data and then communicates risk to the public. When a product has been widely distributed, the news media is used to reach large numbers of people.

Vaping 64

Vaping THC Supply Chain Food 64

WeedAdvisor

JULY 8, 2019

Media outlets like Marijuana Business Daily , however, obtained more information from CannTrust and offer a more complete picture. Ensuring product safety and availability is our priority.”. Eventually, CannTrust pledged to work with Health Canada in ensuring future compliance. The fallout from this situation is catastrophic.

Compliance 63

Compliance Compliance Safety Business 63

Marijuana Lawyer Blog

DECEMBER 7, 2019

And as the epidemic dragged on, news reports covered a notable dip in vape sales, understandably as consumers took a slight step back from vaping until safety could be assured. Since then, data has shown that vaping cannabis sales have stabilized, and even increased market share in a number of states. the week of August 19 to 24.3%

Vaping 52

Vaping Safety Education Dispensary 52

Cannabis Law Report

NOVEMBER 22, 2019

. “MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking.” For media inquiries please contact: Michael Sharp. For more information visit: [link]. 561-627-9455. For Investment Opportunities: MFS Capital Advisors.

DEA 51

DEA Clinical Trials THC Research and Development 51

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

CannaMD

AUGUST 19, 2020

Unlike THC, CBD has a high margin of safety and is well tolerated pharmacologically even after treatments of up to 1500 mg/day for two weeks in both animals and humans, which suggests its feasibility to reduce SARS-CoV2 induced lung inflammation/pathology and disease severity. Our initial data suggest that some C.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

JUNE 20, 2022

The findings in this report point to policies and practices that promote and preserve public health and safety, while allowing legal businesses to compete.”. “We are pleased to release this report that highlights the successful launch of Maine’s adult use market,” said OCP Director Erik Gundersen. “The

Programs 52

Programs Policy Consumption Access 52

Cannabis Law Report

DECEMBER 26, 2021

EBRX-101, a study that will evaluate the pharmacodynamics, pharmacokinetics and safety of a target controlled intravenous infusion of N, N-dimethyltryptamine (DMT) in a population of healthy smokers. For media inquiries, please contact Elizabeth Glassen of BlueSky Communications at: BlueSky Communications. Telephone: +1 (778) 919-8615.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

JULY 13, 2022

The 2022-23 budget and accompanying tax reform bill will provide significant and immediate relief to cannabis businesses, support equity operators, strengthen enforcement tools against illegal cannabis operators, and protect youth, environmental, and public safety programs funding. Supporting equity. million dollars to-date.

Compliance 52

Compliance Compliance Supply Chain Environment 52

United Patients Group

JULY 20, 2024

Prioritize Safety and Privacy When ordering weed online, safety and privacy should always be a concern. Reliable companies will protect your data, such as your address and payment details, through secure systems. A licensed company will only sell products that meet legal safety and quality standards.

Safety 52

Safety Patients Packaging Media 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 40

Clinical Trials Research and Development Data Medicine 40

Cannabis Law Report

DECEMBER 9, 2021

The Company believes the safety and efficacy data collected from the NIDA grant study will support the outcome of their phase 2/3 smoking cessation clinical trial. Preclinical data on numerous sets of Mydecine’s novel compounds are showing significant improvements compared to the first generation of drugs.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Media framing of cannabis. Background.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

APRIL 8, 2021

CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. I postulate that that is correlated to our endocannabinoid system, which good data is now suggesting, is dysregulated in metabolic syndrome: obesity, diabetes, heart disease.

Medicine 108

Medicine Cannabinoids Cannabis THC 108